Technical Analysis for AXGN - AxoGen, Inc.

Grade Last Price % Change Price Change
D 7.71 0.39% 0.03
AXGN closed up 0.39 percent on Monday, March 18, 2024, on 85 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 0.39%
NR7-2 Range Contraction 0.39%
Narrow Range Bar Range Contraction 0.39%
Lower Bollinger Band Walk Weakness 0.39%
Wide Bands Range Expansion 0.39%
Down 3 Days in a Row Weakness 0.39%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 12 hours ago
Outside Day about 12 hours ago
Up 2% about 12 hours ago
60 Minute Opening Range Breakout about 15 hours ago
Up 1% about 15 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AxoGen, Inc. Description

AxoGen, Inc. operates as a regenerative medicine company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve reconstruction solutions, including Avance Nerve Graft, a processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. The company's products are used by surgeons during surgical interventions to repair traumatic nerve injuries. It procures and processes its tissue products in the United States and markets in the United States, Canada, Switzerland, Austria, and Italy. AxoGen, Inc. is headquartered in Alachua, Florida.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Organ Systems Regenerative Medicine Neurosurgery Nervous System Nerve Tissue Products Peripheral Nervous System Surgical Site Submucosa

Is AXGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.8324
52 Week Low 3.45
Average Volume 424,034
200-Day Moving Average 7.32
50-Day Moving Average 9.29
20-Day Moving Average 9.42
10-Day Moving Average 8.37
Average True Range 0.51
RSI (14) 27.01
ADX 44.88
+DI 9.64
-DI 36.20
Chandelier Exit (Long, 3 ATRs) 9.30
Chandelier Exit (Short, 3 ATRs) 9.03
Upper Bollinger Bands 11.66
Lower Bollinger Band 7.18
Percent B (%b) 0.12
BandWidth 47.60
MACD Line -0.49
MACD Signal Line -0.20
MACD Histogram -0.2898
Fundamentals Value
Market Cap 331.87 Million
Num Shares 43 Million
EPS -0.55
Price-to-Earnings (P/E) Ratio -14.02
Price-to-Sales 2.79
Price-to-Book 4.35
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.28
Resistance 3 (R3) 8.27 8.08 8.19
Resistance 2 (R2) 8.08 7.93 8.08 8.15
Resistance 1 (R1) 7.89 7.84 7.99 7.90 8.12
Pivot Point 7.70 7.70 7.74 7.70 7.70
Support 1 (S1) 7.51 7.55 7.61 7.52 7.30
Support 2 (S2) 7.32 7.46 7.32 7.27
Support 3 (S3) 7.13 7.32 7.24
Support 4 (S4) 7.14